Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peanut power: could this snack fight inflammation in seniors?

NCT ID NCT06348771

Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how a peanut-based meal affects inflammation and appetite in 17 older adults who were overweight. Participants ate either a high-saturated-fat meal or a peanut meal rich in healthy unsaturated fats. Researchers measured blood markers of inflammation and hunger to see if peanuts could help reduce post-meal inflammation. The results may help shape future dietary advice for healthy aging.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peanut meal (high in monounsaturated fat)
What this could lead to
If it works, this could point toward simple dietary changes to reduce inflammation and support healthy aging in older adults.
What could go wrong
This is a very small, completed study (17 people) that only looked at short-term effects after a single meal. Results may not apply to long-term health or to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

17 people

The number who actually took part.

Started

Mar 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Older adults across all racial/ethnic groups * Older men, and postmenopausal women \> 2 years since last menses. Exclusion Criteria: * Anemia * Diagnosed with, active, or history of liver cirrhosis, chronic or persisting hepatitis * Diagnosed with, active, or history of cancer * History of gastrointestinal disease or surgical procedure for weight loss. * Diagnosed with immune diseases, type 1 or 2 diabetes, pancreatitis, metabolic bone disease or infectious diseases * Any surgery in the past 6 months * Currently using or have used antibiotics continuously \> 3 days in the past 3 months * Regular use of medications for that affect the gastrointestinal tract, cholecystitis, urinary tract infection, significant renal disease, severe organic diseases including coronary heart disease, myocardial infarction, infectious diseases including pulmonary tuberculosis and AIDS * Known allergy or intolerance to any ingredients in the meal intervention * Recent colonoscopy (within the previous two months) * Uncontrolled hypertension or uncontrolled severe hyperlipidemia. * Participation in another clinical research trial that may interfere with the results of this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy aging Overweight and obesity

Contacts and locations

Locations

  • Foran Hall

    New Brunswick, New Jersey, 08901, United States

  • Rutgers University - NJ Inst Food Nutrition & Health

    New Brunswick, New Jersey, 08901, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.